Evidence map›Paper›PMID 27111534›Full record

ArticleAnesthesiology2016

Effects of γ-Aminobutyric Acid Type A Receptor Modulation by Flumazenil on Emergence from General Anesthesia.

Seyed A Safavynia, Glenda Keating, Iris Speigel, Jonathan A Fidler, Matthias Kreuzer, David B Rye, Andrew Jenkins, Paul S García

Open access · greenAbstract read
In one paragraph

Article in Anesthesiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Direct Structural Insights into GABATrends in biochemical sciences · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Seyed A SafavyniaFrom the Neuroanesthesia Laboratory, Atlanta VA Medical Center/Emory University, Atlanta, Georgia (S.A.S., G.K., I.S., J.A.F., M.K., P.S.G.); Department of Anesthesiology, Weill Cornell Medical College, New York, New York (S.A.S.); Department of Anesthesiology (S.A.S., G.K., J.A.F., M.K., A.J., P.S.G.), Neuroscience Program (I.S., D.B.R., A.J., P.S.G.), and Department of Neurology (G.K., D.B.R.), Emory University, Atlanta, Georgia.
Glenda Keating
Iris Speigel
Jonathan A Fidler
Matthias Kreuzer
David B Rye
Andrew Jenkins
Paul S García
Atlanta VA Medical Center · USEmory University · USCornell University · US

Funding

Effects of Antiretrovirals on Neuronal Health: Screening ARVs for NeurotoxicityIK2BX001677 · VA · VETERANS HEALTH ADMINISTRATION · PI GARCIA, PAUL S · 2014 to 2018
–
BLRD VA IK2 BX001677
6 · The paper itself

Abstract

backgroundTransitions into conscious states are partially mediated by inactivation of sleep networks and activation of arousal networks. Pharmacologic hastening of emergence from general anesthesia has largely focused on activating subcortical monoaminergic networks, with little attention on antagonizing the γ-aminobutyric acid type A receptor (GABAAR). As the GABAAR mediates the clinical effects of many common general anesthetics, the authors hypothesized that negative GABAAR modulators would hasten emergence, possibly via cortical networks involved in sleep.

methodsThe authors investigated the capacity of the benzodiazepine rescue agent, flumazenil, which had been recently shown to promote wakefulness in hypersomnia patients, to alter emergence. Using an in vivo rodent model and an in vitro GABAAR heterologous expression system, they measured flumazenil's effects on behavioral, neurophysiologic, and electrophysiologic correlates of emergence from isoflurane anesthesia.

resultsAnimals administered intravenous flumazenil (0.4 mg/kg, n = 8) exhibited hastened emergence compared to saline-treated animals (n = 8) at cessation of isoflurane anesthesia. Wake-like electroencephalographic patterns occurred sooner and exhibited more high-frequency electroencephalography power after flumazenil administration (median latency ± median absolute deviation: 290 ± 34 s) compared to saline administration (473 ± 186 s; P = 0.042). Moreover, in flumazenil-treated animals, there was a decreased impact on postanesthesia sleep. In vitro experiments in human embryonic kidney-293T cells demonstrated that flumazenil inhibited isoflurane-mediated GABA current enhancement (n = 34 cells, 88.7 ± 2.42% potentiation at 3 μM). Moreover, flumazenil exhibited weak agonist activity on the GABAAR (n = 10 cells, 10.3 ± 3.96% peak GABA EC20 current at 1 μM).

conclusionsFlumazenil can modulate emergence from isoflurane anesthesia. The authors highlight the complex role GABAARs play in mediating consciousness and provide mechanistic links between emergence from anesthesia and arousal.

Indexed as

Anesthesia Recovery PeriodAdministration, IntravenousAnesthesia, InhalationAnesthetics, InhalationAnimalsArousalBehavior, AnimalElectroencephalographyElectromyographyFlumazenilGABA ModulatorsHEK293 CellsHumansIsofluraneMaleRatsAnesthetics, InhalationFlumazenilGABA ModulatorsIsofluraneReceptors, GABA-A

Identifiers

PMID27111534
PMCPMC5326685
OpenAlexW2336320545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.